FDA Inspection 1253907 — Exel Inc.
The FDA completed an inspection of Exel Inc. on Nov 5, 2024 in Bloomington, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 5, 2024
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Bloomington, CA (United States)